Showing results (971-980 of 1,021) with videos related to

Sort By:
Pageof 103
Cancer Medicine|May 22, 2014
FGFR3 expression in primary and metastatic urothelial carcinoma of the bladderElizabeth A Guancial, Lillian Werner, Joaquim Bellmunt, et al.
Journal of Molecular Biology|April 23, 2022
PDBx/mmCIF Ecosystem: Foundational Semantic Tools for Structural BiologyJohn D Westbrook, Jasmine Y Young, Chenghua Shao, et al.
Journal of the National Cancer Institute|March 5, 2020
Risk Stratification of Prostate Cancer Through Quantitative Assessment of PTEN Loss (qPTEN)Tamara Jamaspishvili, Palak G Patel, Yi Niu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2015
Development and clinical validation of an in situ biopsy-based multimarker assay for risk stratification in prostate cancerPeter Blume-Jensen, David M Berman, David L Rimm, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 19, 2016
The γ-Secretase Modulator, BMS-932481, Modulates Aβ Peptides in the Plasma and Cerebrospinal Fluid of Healthy VolunteersHolly D Soares, Maciej Gasior, Jeremy H Toyn, et al.
The American Journal of Surgical Pathology|June 23, 2025
International Society of Urological Pathology Consensus on Cancer Precursor Lesions. Working Group 1: The ProstateKenneth A Iczkowski, Angelo M De Marzo, Neeraj Agarwal, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 6, 2026
Profiling Localized Immunomodulation and Drug Biodistribution within a Subcutaneous Vascularized Niche for Cell TransplantationJocelyn Nikita Campa-Carranza, Simone Capuani, Melissa A Willman, et al.
Journal of Molecular Biology|February 24, 2023
ModelCIF: An Extension of PDBx/mmCIF Data Representation for Computed Structure ModelsBrinda Vallat, Gerardo Tauriello, Stefan Bienert, et al.
Nature Communications|May 31, 2023
In vivo CRISPR screens reveal Serpinb9 and Adam2 as regulators of immune therapy response in lung cancerDzana Dervovic, Ahmad A Malik, Edward L Y Chen, et al.
Journal of Medicinal Chemistry|January 19, 1996
Discovery of 1,5-benzodiazepines with peripheral cholecystokinin (CCK-A) receptor agonist activity. 1. Optimization of the agonist "trigger"C J Aquino, D R Armour, J M Berman, et al.
Pageof 103